Drug Information

Drug General Information
Drug ID
D0GE2F
Former ID
DIB000354
Drug Name
GSK-2485852
Synonyms
GL-60667; GSK-2485852A; NVP-LDI133; HCV RNA polymerase inhibitors, Genelabs/Novartis; NS5b non-nucleoside inhibitors (HCV infection), GSK/Novartis; NS5b non-nucleoside inhibitors (HCV), Genelabs/Novartis
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Terminated [548323]
Company
Genelabs Technologies Inc
Structure
Download
2D MOL
Target and Pathway
Target(s) Hepatitis C virus NS5B polymerase Target Info Inhibitor [532455]
References
Ref 548323Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024593)
Ref 532455In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor. Antimicrob Agents Chemother. 2013 Nov;57(11):5216-24.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.